Merck Says Vaccine Case 'Poor Vehicle' For Antitrust Review
By Benjamin Morse · September 16, 2025, 9:34 PM EDT
Merck & Co. told the U.S. Supreme Court to reject a bid from physicians looking to revive antitrust claims over submissions the pharmaceutical giant made to federal regulators concerning its mumps vaccine,...
To view the full article, register now.